{"id":10715,"date":"2019-08-13T00:00:56","date_gmt":"2019-08-13T00:00:56","guid":{"rendered":"https:\/\/www.olartemoure.com\/?p=10715"},"modified":"2019-08-12T15:36:14","modified_gmt":"2019-08-12T15:36:14","slug":"colombia-sic-sanctions-pharma-corporations-olartemoure","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/","title":{"rendered":"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices"},"content":{"rendered":"

On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companie<\/a>s<\/a>\u00a0for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia.<\/p>\n

The COP 82,811,600 fine was imposed for the sale of 7 different medications, each independently exceeding in 4%, 19%, 76%, 43%, 295%, 348% and up to 651% the established ceiling prices.<\/p>\n

The medications sold at the unauthorized prices are used in ophthalmological and mental disorders, as well as for the treatment of epilepsy, bedwetting, and overactive bladder.<\/p>\n

Furthermore, the SIC decided to: i) issue an order to further investigate other pharmaceutical companies; and, ii) fine one of the sanctioned companies for not submitting information to the SIC, in accordance to law.<\/p>\n","protected":false},"excerpt":{"rendered":"

On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies\u00a0for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia. The COP 82,811,600 fine was imposed for the sale of 7 different […]<\/p>\n","protected":false},"author":2,"featured_media":10717,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[47,109,160],"tags":[],"class_list":["post-10715","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-regulatory-affairs","category-consumer-law"],"yoast_head":"\nColombia: SIC sanctions pharma corporations | OlarteMoure<\/title>\n<meta name=\"description\" content=\"the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices\" \/>\n<meta property=\"og:description\" content=\"On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia. The COP 82,811,600 fine was imposed for the sale of 7 different medications, each independently exceeding in 4%, 19%, 76%, 43%, 295%, 348% and up to 651% the established ceiling prices. The medications sold at the unauthorized prices are used in ophthalmological and mental disorders, as well as for the treatment of epilepsy, bedwetting, and overactive bladder. Furthermore, the SIC decided to: i) issue an order to further investigate other pharmaceutical companies; and, ii) fine one of the sanctioned companies for not submitting information to the SIC, in accordance to law.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-13T00:00:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Diego Bernal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices\" \/>\n<meta name=\"twitter:description\" content=\"On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia. The COP 82,811,600 fine was imposed for the sale of 7 different medications, each independently exceeding in 4%, 19%, 76%, 43%, 295%, 348% and up to 651% the established ceiling prices. The medications sold at the unauthorized prices are used in ophthalmological and mental disorders, as well as for the treatment of epilepsy, bedwetting, and overactive bladder. Furthermore, the SIC decided to: i) issue an order to further investigate other pharmaceutical companies; and, ii) fine one of the sanctioned companies for not submitting information to the SIC, in accordance to law.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Diego Bernal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/\"},\"author\":{\"name\":\"Diego Bernal\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\"},\"headline\":\"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices\",\"datePublished\":\"2019-08-13T00:00:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/\"},\"wordCount\":139,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/08\\\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg\",\"articleSection\":[\"News\",\"Regulatory Affairs\",\"Consumer Law\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/\",\"name\":\"Colombia: SIC sanctions pharma corporations | OlarteMoure\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/08\\\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg\",\"datePublished\":\"2019-08-13T00:00:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\"},\"description\":\"the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/08\\\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2019\\\/08\\\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg\",\"width\":800,\"height\":350,\"caption\":\"OlarteMoure - Autoridad Colombiana en Metrolog\u00eda - Colombia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/colombia-sic-sanctions-pharma-corporations-olartemoure\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/b66ca4b152a396f32fd6e5c48395ce14\",\"name\":\"Diego Bernal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g\",\"caption\":\"Diego Bernal\"},\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/dsb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Colombia: SIC sanctions pharma corporations | OlarteMoure","description":"the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/","og_locale":"en_US","og_type":"article","og_title":"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices","og_description":"On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia. The COP 82,811,600 fine was imposed for the sale of 7 different medications, each independently exceeding in 4%, 19%, 76%, 43%, 295%, 348% and up to 651% the established ceiling prices. The medications sold at the unauthorized prices are used in ophthalmological and mental disorders, as well as for the treatment of epilepsy, bedwetting, and overactive bladder. Furthermore, the SIC decided to: i) issue an order to further investigate other pharmaceutical companies; and, ii) fine one of the sanctioned companies for not submitting information to the SIC, in accordance to law.","og_url":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2019-08-13T00:00:56+00:00","og_image":[{"width":800,"height":350,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg","type":"image\/jpeg"}],"author":"Diego Bernal","twitter_card":"summary_large_image","twitter_title":"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices","twitter_description":"On 31 July, the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012, issued by the National Commission for Market Control of Medications and Medical Devices, which establishes ceiling pricing for certain medications in Colombia. The COP 82,811,600 fine was imposed for the sale of 7 different medications, each independently exceeding in 4%, 19%, 76%, 43%, 295%, 348% and up to 651% the established ceiling prices. The medications sold at the unauthorized prices are used in ophthalmological and mental disorders, as well as for the treatment of epilepsy, bedwetting, and overactive bladder. Furthermore, the SIC decided to: i) issue an order to further investigate other pharmaceutical companies; and, ii) fine one of the sanctioned companies for not submitting information to the SIC, in accordance to law.","twitter_misc":{"Written by":"Diego Bernal","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/"},"author":{"name":"Diego Bernal","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14"},"headline":"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices","datePublished":"2019-08-13T00:00:56+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/"},"wordCount":139,"commentCount":0,"image":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg","articleSection":["News","Regulatory Affairs","Consumer Law"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/","url":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/","name":"Colombia: SIC sanctions pharma corporations | OlarteMoure","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg","datePublished":"2019-08-13T00:00:56+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14"},"description":"the Colombian National Authority on Metrology (SIC) hit pharmaceutical companies for failing to comply with Circular 04 of 2012.","breadcrumb":{"@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2019\/08\/190808-Imagenes-OMWD-semana-5-al-9_Noticia-2.jpg","width":800,"height":350,"caption":"OlarteMoure - Autoridad Colombiana en Metrolog\u00eda - Colombia"},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/en\/colombia-sic-sanctions-pharma-corporations-olartemoure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"Colombia: SIC sanctions pharma corporations for the sale of medications in excess of ceiling prices"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/b66ca4b152a396f32fd6e5c48395ce14","name":"Diego Bernal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/98e19bbd1dde17a81a7a8ac596fcdab15de47e6ad6983172a99e27f2b531058b?s=96&d=mm&r=g","caption":"Diego Bernal"},"url":"https:\/\/olartemoure.com\/en\/author\/dsb\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/10715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=10715"}],"version-history":[{"count":0,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/10715\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/10717"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=10715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=10715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=10715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}